Biosimilars, toripalimab, and TIGIT with the CEO of Coherus.
- blonca9
- Jun 3, 2023
- 1 min read
Updated: Jun 15, 2023
Coherus Biosciences CEO Denny Lanfear talks about trying to lower the cost of medicines through biosimilars and discusses his oncology programs.